It is allegedly known that the thermal stability of the Mint Lift® (the Mint Lift® 17 and the Mint Lift® Fine; HansBiomed Co., Ltd., Seoul, Korea) over time might be lower as compared with thread-lifts processed through ultrasonic molding technology, such as the MEDI ROPE (WSM 19-03; CNG Co., Ltd., Gyeonggi, Korea), because the Mint Lift® undergoes a thermal treatment during the manufacturing process. We conducted this accelerated aging test to compare the thermal stability over time between the Mint Lift® and the MEDI ROPE. Thus, we measured the degrees of strength of the MEDI ROPE, the Mint Lift® 17, and the Mint Lift® Fine at 0, 2, 3, 4, 5, 7, 8, 9, 10, 11, 14, and 17 weeks. Between 0 and 14 weeks, the Mint Lift® 17 and the Mint Lift® Fine had significantly higher degrees of strength as compared with the MEDI ROPE (p < 0.05). At 0, 5, and 10 weeks, the Mint Lift® 17 and the Mint Lift® Fine showed no notable differences in microscopic findings as compared with the MEDI ROPE. At 20 weeks, however, the integrities of the Mint Lift® 17 and the Mint Lift® Fine were better preserved as compared with the MEDI ROPE. In conclusion, our results indicate that the Mint Lift® 17 and the Mint Lift® Fine might be less vulnerable to degradation over time as compared with the MEDI ROPE under thermal conditions.

Purpose: Ventilator-associated pneumonia is the most common nosocomial infection in patients with mechanical ventilation. In 2013, the new concept of ventilator- associated events (VAEs) replaced the traditional concept of ventilator-associated pneumonia. We analyzed risk factors for VAE occurrence and in-hospital mortality in trauma patients who received mechanical ventilatory support.Methods: In this retrospective review, the study population comprised patients admitted to the Jeju Regional Trauma Center from January 2020 to January 2021. Data on demographics, injury characteristics, and clinical findings were collected from medical records. The subjects were categorized into VAE and no-VAE groups according to the Centers for Disease Control and Prevention/National Healthcare Safety Network VAE criteria. We identified risk factors for VAE occurrence and in-hospital mortality.Results: Among 491 trauma patients admitted to the trauma center, 73 patients who received ventilator care were analyzed. Patients with a chest Abbreviated Injury Scale (AIS) score ≥3 had a 4.7-fold higher VAE rate (odds ratio [OR], 4.73; 95% confidence interval [CI], 1.46–17.9), and those with a glomerular filtration rate (GFR) <75 mL/min/1.73 m2 had 4.1-fold higher odds of VAE occurrence (OR, 4.15; 95% CI, 1.32–14.1) and a nearly 4.2-fold higher risk for in-hospital mortality (OR, 4.19; 95% CI, 1.30–14.3). The median VAE-free duration of patients with chest AIS ≥3 was significantly shorter than that of patients with chest AIS <3 (P=0.013).Conclusions: Trauma patients with chest AIS ≥3 or GFR <75 mL/min/1.73 m2 on admission should be intensively monitored to detect at-risk patients for VAEs and modify the care plan accordingly. VAEs should be closely monitored to identify infections early and to achieve desirable results. We should also actively consider modalities to shorten mechanical ventilation in patients with chest AIS ≥3 to reduce VAE occurrence.